Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: No difference in the high- and low-risk groups-Reference-Cited by-同舟云学术

Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: No difference in the high- and low-risk groups

Published:2014-09-02 Issue:7 Volume:136 Page:1697-1707
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Mo Xiao-Dong¹,Xu Lan-Ping¹,Zhang Xiao-Hui¹,Liu Dai-Hong¹,Wang Yu¹,Chen Huan¹,Yan Chen-Hua¹,Chen Yu-Hong¹,Han Wei¹,Wang Feng-Rong¹,Wang Jing-Zhi¹,Liu Kai-Yan¹,Huang Xiao-Jun¹²

Affiliation:

1. Peking University People's Hospital & Peking University Institute of Hematology; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation; No. 11 Xizhimen South Street, Xicheng District Beijing 100044 China

2. Peking-Tsinghua Center for Life Sciences; Beijing 100871 China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993);Goldstone;Blood,2008

2. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission;Pidala;Cochrane Database Syst Rev,2011

3. Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?;Nishiwaki;Bone Marrow Transplant,2013

4. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation;Lu;Blood,2006

5. Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go;Lv;J Hematol Oncol,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation of the TP53 gene in acute lymphoblastic leukemia does not affect survival outcomes after haploidentical hematopoietic stem cell transplantation;International Journal of Cancer;2022-10-26

2. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia;Blood Advances;2022-01-11

3. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia;Frontiers in Immunology;2021-05-07

4. G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study;Frontiers in Oncology;2021-03-15

5. Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2021-03-13